Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma
SourceJournal of Clinical Oncology, 16, 8, (1998), pp. 2708-2714
Article / Letter to editor
Display more detailsDisplay less details
Journal of Clinical Oncology
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.